top of page
Trials and Tribulations: Part II of the Neuwave Story with Dr. Dan van der Weide, Dr. Fred Lee, Dr. Bryan Hartley on the BackTable Industry Podcast
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Industry

Episode # 24  •  28 Apr 2022

Trials and Tribulations: Part II of the Neuwave Story

We talk with electrical engineering professor Dr. Dan van der Weide and interventional radiologist Dr. Fred Lee about the lessons they learned in the early stages of founding their microwave ablation device company, including challenges with early teams and equity.

Resources

You may also like

See more of the content that's relevant to your practice.

More about this episode

In this episode, our host Dr. Bryan Hartley interviews electrical engineering professor Dr. Dan van der Weide and interventional radiologist Dr. Fred Lee about the lessons they learned in the early stages of founding their microwave ablation device company, including challenges with early teams and equity. This is the second installment of a three-part series about the origin, rise, and acquisition of NeuWave.

The founders start by discussing the nature of their successful partnership and how each of them brought complementary perspectives to the company. On one hand, Dr. Lee has clinical experience that informs him about current medical devices and their limitations. Conversely, Dr. van der Weide has a broad-based understanding of energy and how it can be applied to medicine. Even after the acquisition of NeuWave, the two founders have continued to innovate and start subsequent new companies together.

While the founders shared a common vision, they had early NeuWave experiences which taught them about team conflict. They share a salient lesson learned from hiring team members based on prior social connections instead of objective skill sets. Dr. Van der Weide warns against taking mental shortcuts and making assumptions about a person’s abilities, without first examining their experience in the startup world. He also gives advice on equity apportionment, saying that vesting schedules should be based on clear milestones, instead of a pre-set percentage.

Finally, we discuss NeuWave’s early venture capital funding and the importance of choosing an investor that understands the vision and is willing to dedicate their honest effort to helping when obstacles arise.

Stay tuned for the third installment!

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page